Latest Articles

  • Dual antiplatelet therapy for acute coronary syndromes: How long to continue?
    Dual antiplatelet therapy for acute coronary syndromes: How long to continue?
    Meghana Halkar, MD and A. Michael Lincoff, MD
    Cleveland Clinic Journal of Medicine September 2016, 83 (9) 675-688; DOI: https://doi.org/10.3949/ccjm.83a.15092

    After drug-eluting stent placement, at least 12 months of dual antiplatelet therapy is recommended. Would longer be better?

  • Pancreatectomy and islet cell autotransplantation (June 2016)
    Cleveland Clinic Journal of Medicine September 2016, 83 (9) 644;

    An error appeared in the article “Total pancreatectomy and islet cell autotransplantation: Defi nitive treatment for chronic pancreatitis” (Arce KM, Lin YK, Stevens T, Walsh RM, Hatipoglu BA. Cleve Clin J Med 2016; 83:435–442.)

  • Erythrocytosis due to presumed polycythemia vera
    Rushad Patell, MD, Karl Theil, MD and Alan Lichtin, MD
    Cleveland Clinic Journal of Medicine September 2016, 83 (9) 648-653; DOI: https://doi.org/10.3949/ccjm.83a.15154

    Erythrocytosis has a variety of potential causes.

  • Are there alternatives to surgery for Zenker diverticulum?
    Nitin Aggarwal, MD and Prashanthi N. Thota, MD, FACG
    Cleveland Clinic Journal of Medicine September 2016, 83 (9) 645-647; DOI: https://doi.org/10.3949/ccjm.83a.15006

    High rates of complications in elderly patients have led to the development of endoscopic procedures.

  • Managing irritable bowel syndrome: The low-FODMAP diet
    Mohannad Dugum, MD, Kathy Barco, RD, LD, CNSC and Samita Garg, MD
    Cleveland Clinic Journal of Medicine September 2016, 83 (9) 655-662; DOI: https://doi.org/10.3949/ccjm.83a.14159

    A diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) reduces symptoms.

  • The people behind the Journal really matter
    Brian F. Mandell, MD, PhD and John Clough, MD
    Cleveland Clinic Journal of Medicine September 2016, 83 (9) 631-632; DOI: https://doi.org/10.3949/ccjm.83b.09016

    This month, the Journal bids farewell to sales and marketing director Joe Dennehy and deputy editor Jim Pile.

  • Thrombotic thrombocytopenic purpura: The role of ADAMTS13
    Heesun J. Rogers, MD, PhD, Charles Allen, DO and Alan E. Lichtin, MD
    Cleveland Clinic Journal of Medicine August 2016, 83 (8) 597-603; DOI: https://doi.org/10.3949/ccjm.83a.15009

    ADAMTS13 testing is useful in diagnosing this disease, guiding therapy, and predicting relapse.

  • Geographic tongue
    Ceena Neena Jacob, MD, Teny Mathew John, MD, DNB and R. Jayaprakash, MD
    Cleveland Clinic Journal of Medicine August 2016, 83 (8) 565-566; DOI: https://doi.org/10.3949/ccjm.83a.14011

    Although striking, the lesion is benign and self-limiting and rarely warrants further investigation.

  • Measles: More than the rash (May 2016)
    Burke A. Cunha, MD
    Cleveland Clinic Journal of Medicine August 2016, 83 (8) 555-556; DOI: https://doi.org/10.3949/ccjm.83c.08003

    Readers comment on recognizing the signs of measles (May 2016)

  • Trust the thyroid thermostat
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine August 2016, 83 (8) 552-553; DOI: https://doi.org/10.3949/ccjm.83b.08016

    Why do some physicians persist in regularly following the T3 and T4 levels in addition to the TSH?

Pages